Take Responsibility for Your Own Breast Health
Most of us can appreciate the importance of early detection having been touched by someone with breast cancer, however many women remain unaware about the importance of knowing their own breast density to ensure that their breast screening needs are properly being met. Breast density is a key risk factor for 40% of women and should be carefully considered along with other risk factors when determining which screening methods are best suited for them, in light of mammographic detection limitations in dense breast tissue.
Fortunately, both patients and clinicians now have easier and earlier access to a new 3D automated breast ultrasound technology that can accurately and safely screen for breast cancer, especially in dense breast tissue, and provide supplemental and comparative information about structural changes and risk over time, allowing for earlier detection and successful treatments using less invasive protocols.
A Key to A Women’s Health and Survival is Early Detection
Preview Breast Screening offers 3D Automated Breast Ultrasound (ABUS) screening to individuals starting as early as in their 20s, allowing for safe and comfortable assessment and monitoring of potential breast tissue structural changes, especially in dense breast tissue. Fortunately, ABUS allows for the accurate identification, differentiation and monitoring of the majority of low risk abnormalities, as well as for the localization, sizing, and characterization of suspicious higher risk pre-cancerous or cancerous abnormalities or changes, when they are smaller and easier to resolve.
ABUS is a SMART Choice for Safe, Gentle, and Accurate Breast Screening For All Women – No Referral Required!
ABUS is available to all individuals, regardless of age or breast cancer risk, who seek a better understanding of their own breast health, when earlier and easier access to screening are important considerations for monitoring and proactive response to potential concerns. ABUS is safe and gentle for use by younger, pregnant or lactating women who are especially concerned about the radiation exposure and heavy compression of mammography. It’s also ideal for higher risk women with a surgical history of breast implants, post-operative or scarred breast tissue. There is no longer any need to wait for symptoms to persist or for clinicians to address your breast health needs. Now you can proactively self-initiative to get an accurate ABUS baseline or followup interval comparison as frequently as needed, to monitor any breast tissue changes that may occur without the need for a doctor’s referral or requisition.
ABUS is the Latest Technological Advancement in Breast Imaging
ABUS is the latest technological advancement in breast imaging from GE Healthcare. It’s the newest 3D automated ultrasound medical device exclusively developed and designed for breast screening which is FDA and Health Canada approved for use as an adjunct to mammography. Although ABUS is commonly accessed by women with known breast abnormality or symptoms, it is especially useful for screening proactive health-conscious women as well as higher risk, asymptomatic or dense-breasted women who may fall outside the screening guidelines for provincial health insurance coverage for various reasons. For instance, they may be too young or without a proven family history of breast cancer for earlier and more routine screening.
ABUS Delivers Exceptional Image Quality for Accurate Interval Comparison
ABUS delivers exceptional 3D image quality using a large automated scanning probe that virtually eliminates operator skill variability. The system works by positioning a sheer membrane gently on the breast after application of a conductive gel. With three sweeps of the scanning probe over each breast, hundreds of breast tissue image slices are automatically generated of the entire breast in just minutes. The software creates 3D-reconstructed images showing precise anatomical detail of complex breast tissues and structures for the radiologist to review and interpret. This is particularly useful for the radiologist who can now look through hundreds of breast tissue image “slices” back to the chest wall, virtually peeling back the layers of challenging dense breast tissue to visualize cancers, which may have been hidden by dense tissue on a mammogram. ABUS 3D screening software allows for accurate interval comparison of the entire breast area over time compared to operator-dependent 2D handheld ultrasound which is primarily indicated for diagnostic spot-checking purposes only following a mammogram.
Mammography Alone is Not Enough for Women with Dense Breasts
ABUS is not meant as a replacement of mammography for screening, but rather as an adjunct to help detect and differentiate smaller tumours particularly in women with dense tissue who are at an increased risk for breast cancer. In women with dense tissue, there is an increased risk of undetected cancer lesions when using mammography alone. The detection rate of smaller than 1 cm size cancer lesions is increased 50% by ABUS, to that of mammography alone. Supplementing mammography with ABUS can significantly increase detection rates making treatment programs more successful after being initiated sooner. This is of particular importance considering 40% of North American women have dense breasts. Consequently, many women with higher breast density and repeated negative or inconclusive findings from annual or semi-annual mammograms, are choosing ABUS for its added detection value, allowing them to reduce their mammographic screening frequency, given their concerns about cumulative radiation exposure and painful tissue compression. To learn more about the importance of knowing your breast density and the advantages of supplementing mammography screening with ABUS go to (www.densebreastscanada.ca) .